摘要
There is strong evidence that inhibition of one or more Aldehyde Dehydrogenase 1A (ALDH1A) isoforms may be beneficial in chemotherapy-resistant ovarian cancer and other tumor types. While many previous efforts have focused on development of ALDH1A1 selective inhibitors, the most deadly ovarian cancer subtype, high-grade serous (HGSOC), exhibits elevated expression of ALDH1A3. Herein, we report continued development of pan-ALDH1A inhibitors to assess whether broad spectrum ALDH1A inhibition is an effective adjunct to chemotherapy in this critical tumor subtype. Optimization of the CM39 scaffold, aided by metabolite ID and several new ALDH1A1 crystal structures, led to improved biochemical potencies, improved cellular ALDH inhibition in HGSOC cell lines, and substantial improvements in microsomal stability culminating in orally bioavailable compounds. We demonstrate that two compounds 68 and 69 are able to synergize with chemotherapy in a resistant cell line and patient-derived HGSOC tumor spheroids, indicating their suitability for future in vivo proof of concept experiments.
学科与关键词
- Blockade of ALDH in Cisplatin-Resistant Ovarian Cancer Stem Cells In Vitro Synergistically Enhances Chemotherapy-Induced Cell DeathGuo, Fang; Yang, Zhi; Sehouli, Jalid; Kaufmann, Andreas M.*Current Oncology, 2022, 29(4): 2808-2822.被引 9
- ALDH1A1 promotes PARP inhibitor resistance by enhancing retinoic acid receptor-mediated DNA polymerase θ expressionLavudi Kousalya; Banerjee Ananya; Li Na; Yang Yajing; Cai Shurui; Bai Xuetao; Zhang Xiaoli; Li Aidan; Wani Elsa; Yang Shyh-Ming; Zhang Junran; Rai Ganesha; Backes Floor; Patnaik Srinivas; Guo Peixuan; Wang Qi-Ennpj Precision Oncology, 2023, 7(1): 66.
- Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer culturesDaniel K Chan; W MiskiminsJournal of Ovarian Research, 2012, 5(1): 19.
